NRG-BN003

Open to Accrual

Return to Protocol Table

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma

Principal Investigator

Leland Rogers

Status

Open to Accrual

Date Opened To Accrual

June 14, 2017


Disease Site

Brain [BN] Benign Brain Tumors

Phase

III

Developmental Therapeutics

No

Primary Objective

The primary endpoint is progression-free survival (PFS).  The principle objective is to determine the extent of clinical benefit of the addition of adjuvant radiotherapy (RT) to gross total resection (GTR) for patients with newly diagnosed World Health Organization (WHO) grade II meningioma.

Patient Population

Newly diagnosed gross totally resected (Simpson Grade 1-3) WHO grade II meningioma

Target Accrual

133

Protocol Documents

Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.


Patient Study Webpage

To learn more about this study, visit the Patient Study Webpage.